A switch in the direction of the effect of insulin on the partitioning of hepatic fatty acids for the formation of secreted triacylglycerol occurs in vivo, as predicted from studies with perfused livers

European Journal of Biochemistry

Volumn 267, Issue 4, 2000, Pages 935-941

  Rennie, Susan M ^a   Park, Byun Sung ^a,b   Zammit, Victor A ^a  

^a HANNAH RESEARCH INSTITUTE   (United Kingdom)

^b Kangwon National University   (South Korea)

Author keywords

Fatty acids; Liposomes; Partitioning; Secretion; Very low density lipoprotein

Indexed keywords

FATTY ACID; INSULIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; FEMALE; HORMONAL REGULATION; INSULIN RESPONSE; LIPOPROTEIN SYNTHESIS; LIVER METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CHRONIC DISEASE; DRUG CARRIERS; FASTING; FATTY ACIDS; FEMALE; HUMANS; HYPERINSULINISM; HYPERTRIGLYCERIDEMIA; INSULIN; LIPOPROTEINS, VLDL; LIPOSOMES; LIVER; PERFUSION; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; TRIGLYCERIDES;

ANIMALIA;

EID: 0033977880     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01126.x     Document Type: Article

References (54)

1. 1. Zilversmit, D.B. (1995) Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin. Chem. 41, 153-158.
2. 2. Phillips, N.R., Waters, D. & Havel, R.J. (1993) Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 88, 2762-2770.
3. 3. Havel, R.J. (1994) Postprandial hyperlipidemia and remnant lipoproteins. Curr. Opin. Lipidol. 5, 102-109.
4. 4. Reaven, G.M. (1992) The role of insulin resistance and hyperinsulinemia in coronary heart disease. Metabolism 41, 16-19.
5. 5. Lewis, G.F., Uffelman, K.D., Szeto, L.W., Weller, B. & Steiner, G. (1995) Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J. Clin. Invest. 95, 158-166.
6. 6. Frayn, K.N. (1993) Insulin resistance and lipid metabolism. Curr. Opin. Lipidol. 4, 197-204.
7. 7. Lewis, G.F. & Steiner, G. (1996) Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state. Diabetes Care 19, 390-393.
8. 8. Sparks, J.D. & Sparks, C.E. (1993) Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Curr. Opin. Lipidol. 4, 177-186.
9. 9. Sparks, J.D. & Sparks, C.E. (1993) Hormonal regulation of lipoprotein assembly and secretion. Curr. Opin. Lipidol. 4, 177-186.
10. 10. Arrol, S., Mackness, M.I., Laing, I. & Durrington, P.N. (1994) Effects of insulin and glucagon on the secretion of apolipoprotein B-containing lipoproteins and triacylglycerol synthesis by human hepatoma (Hep G2) cells. Diab. Nutr. Metab. 7, 263-271.
11. 11. Bartlett, S.M. & Gibbons, G.F. (1988) Short-and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin. Biochem. J. 249, 37-43.
12. 12. Durrington, P.N., Newton, R.S., Weinstein, D.B. & Steinberg, D. (1982) Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J. Clin. Invest. 70, 63-73.
13. 13. Sparks, J.D. & Sparks, C.E. (1990) Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J. Biol. Chem. 15, 8854-8862.
14. 14. Lankester, D., Brown, A. & Zammit, V. (1998) Use of cytosolic triacylglycerol hydrolysis products and of exogenous fatty cid for the synthesis of triacylglycerol secreted by cultured hepatocytes. J. Lipid Res. 39, 1889-1895.
15. 15. Zammit, V.A., Lankester, D.J., Brown, A.M. & Park, B.S. (1999) Insulin stimulates triacylglycerol secretion by perfused livers from fed rats but inhibits it in livers from fasted or insulin-deficient rats implications for the relationship between hyperinsulinaemia and hypertriglyceridaemia. Eur. J. Biochem. 263, 859-864.
16. 16. Topping, D.L. & Mayes, P.A. (1972) The immediate effects of insulin and fructose on the metabolism of the perfused liver. Biochem. J. 126, 295-311.
17. 17. Lewis, G.F. (1997) Fatty acid regulation of very low density lipoprotein production. Curr. Opin. Lipidol. 8, 146-153.
18. 18. Malmstrom, R., Packard, C.J., Caslake, M., Bedford, D., Stewart, P., Yki-Jarvinen, H., Shepherd, J. & Taskinen, M.R. (1998) Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes 47, 779-787.
19. 19. Steiner, G., Haynes, F.J., Yoshino, G. & Vranic, M. (1984) Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics. Am. J. Physiol. 246, E187-E192.
20. 20. Zammit, V.A. & Moir, A.M.B. (1994) Monitoring the partitioning of hepatic fatty acids in vivo: keeping track of control. Trends Biochem. Sci. 19, 313-317.
21. 21. Spangler, R.S. (1990) Insulin administration via liposomes. Diabetes Care 13, 911-922.
22. 22. Olefsky, J.M., Farquhar, J.W. & Reaven, G.M. (1974) Reappraisal of the role of insulin in hypertriglyceridemia. Am. J. Med. 57, 551-560.
23. 23. Reaven, G.M. (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595-1607.
24. 24. Reaven, G.M. & Laws, A. (1994) Insulin resistance, compensatory hyperinsulinaemia and coronary heart disease. Diabetologia 37, 948-952.
25. 25. Drynan, L., Quant, P.A. & Zammit, V.A. (1996) The role of changes in the sensitivity of hepatic mitochondrial overt carnitine palmitoyltransferase in determining the onset of the ketosis of starvation in the rat. Biochem. J. 317, 791-795.
26. 26. Moir, A.M.B. & Zammit, V.A. (1993) Monitoring of changes in hepatic fatty acid and glycerolipid metabolism during the starved-to-fed transition in vivo. Studies on awake, unrestrained rats. Biochem. J. 289, 49-55.
27. 27. Mayer, L.D., Hope, M.J. & Cullis, P.R. (1986) Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim. Biophys. Acta 858, 161-168.
28. 28. Sammons, M.C., DeMark, B.R. & McCracken, M.S. (1986) Determination of total and encapsulated insulin in a vesicle formulation. J. Pharm. Sci. 75, 838-841.
29. 29. Goll, J.H. & Stock, G.B. (1977) Determination by photon correlation spectroscopy of particle size distributions in lipid vesicle suspensions. Biophys. J. 19, 265-273.
30. 30. Leturque, A., Burnol, A., Ferre, P. & Girard, J. (1984) Pregnancy-induced insulin resistance in the rat: assessment by glucose clamp technique. Am. J. Physiol. 246, E25-E31.
31. 31. Abra, R.M., Bosworth, M.E. & Hunt, C.A. (1980) Liposome disposition in vivo: effects of pre-dosing with lipsomes. Res. Commun Chem Pathol Pharmacol. 29, 349-360.
32. 32. Moir, A.M.B. & Zammit, V.A. (1992) Selective labelling of hepatic fatty acids in vivo. Studies on the synthesis and secretion of glycerolipids in the rat. Biochem. J. 283, 145-149.
33. 33. Dragsten, P., Mitchell, D., Covert, G. & Baker, T. (1987) Drug delivery using vesicles targeted to the asialoglycoprotein receptor. Biochim. Biophys. Acta 926, 270-279.
34. 34. Spangler, R.S. (1985) Selective insulinization of liver in conscious diabetic dogs. Am. J. Physiol. 249, E152-E159.
35. 35. Spangler, R.S., Triebwasser, K.C. & Wilson, M.L. (1986) Effect of charge on hepatic specific nature of vesicle encapsulated insulin in conscious dogs. Am. J. Physiol. 251, E591-E596.
36. 36. Holder, J.C., Zammit, V.A. & Robinson, D.S. (1990) The preferential uptake of very-low-density lipoprotein cholesteryl ester by rat liver in vivo. Biochem. J. 272, 735-741.
37. 37. Lewis, G.F., Uffelman, K.D., Szeto, L.W. & Steiner, G. (1993) Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 42, 833-842.
38. 38. Lewis, G.F. (1997) Fatty acid regulation of very low density lipoprotein production. Curr. Opin. Lipidol. 8, 146-153.
39. 39. Malmstrom, R., Packard, C.J., Caslake, M., Bedford, D., Stewart, P., Yki-Jarvinen, H., Shepherd, J. & Taskinen, M.-R. (1997) Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 40, 454-462.
40. 40. Malmstrom, R., Packard, C.J., Watson, T.D., Rannikko, S., Caslake, M., Bedford, D., Stewart, P., Yki-Jarvinen, H., Shepherd, J. & Taskinen, M.R. (1997) Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler. Thromb. Vasc. Biol. 17, 1454-1464.
41. 41. Steiner, G. (1991) Insulin regulation of triglyceride metabolism. Atherosclerosis Rev. 22, 27-32.
42. 42. Steiner, G. & Lewis, G. (1996) Hyperinsulinemia and triglyceride-rich lipoproteins. Diabetes 45, S24-S26.
43. 43. Aarsland, A., Chinkes, D. & Wolfe, R.R. (1996) Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J. Clin. Invest 98, 2008-2017.
44. 44. The Diabetes Control & Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J Med. 329, 977-986.
45. 45. Haffner, S.M. (1998) Issues in management: the role of insulin in cardiovascular outcomes. Diabetes Metab Rev. 14 (Suppl. 1), S51-S56.
46. 46. Flodin, N.W. (1986) Atherosclerosis: an insulin-dependent disease? J. Am. Coll Nutr 5, 417-427.
47. 47. Abraira, C., Colwell, J.A., Nuttall, F., Emanuele, N., Comstock, J., Levin, S., Sawin, C. & Silbert, C. (1998) A critical issue. Intensive insulin treatment and macrovascular disease. Diabetes Care 21, 669-671.
48. 48. Balkau, B., Tichet, J., Caces, E., Vol, S., Eschwege, E. & Cahane, M. (1998) Insulin dose and cardiovascular risk factors in type 1 diabetic children and adolescents. Diabetes Metab. 24, 143-150.
49. 49. Pontiroli, A.E., Pacchioni, M., Camisasca, R. & Pozza, G. (1995) The possible role of insulin release in cardiovascular morbidity and mortality in NIDDM patients. Diabetes Care 18, 1506.
50. 50. Despres, J.P., Lamarche, B., Mauriege, P., Cantin, B., Dagenais, G.R., Moorjani, S. & Lupien, P.J. (1996) Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334, 952-957.
51. 51. Haffner, S.M., Mykkanen, L., Stern, M.R, Valdez, R.A., Heisserman, J.A. & Bowsher, R.R. (1993) Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects. Diabetes 42, 1297-1302.
52. 52. Nagi, D.K., Hendra, T.J., Ryle, A.J., Cooper, T.M., Temple, R.C., Clark, P.M., Schneider, A.E., Hales, C.N. & Yudkin, J.S. (1990) The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 33, 532-537.
53. 53. Abraha, A., Humphreys, S., Clark, M., Matthews, D. & Frayn, K. (1998) Acute effects of fructose and postprandial lipaemia in diabetic and non-diabetic subjects. Br. J. Nutr. 80, 169-175.
54. 54. Reaven, G.M. (1993) Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitus. Diabetes Metab. Rev. 9, 5S-12S.